<?xml version="1.0" encoding="UTF-8"?>
<ref id="B99">
 <label>99.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kufel</surname>
    <given-names>WD</given-names>
   </name>
   <name>
    <surname>Devanathan</surname>
    <given-names>AS</given-names>
   </name>
   <name>
    <surname>Marx</surname>
    <given-names>AH</given-names>
   </name>
   <name>
    <surname>Weber</surname>
    <given-names>DJ</given-names>
   </name>
   <name>
    <surname>Daniels</surname>
    <given-names>LM</given-names>
   </name>
  </person-group>. 
  <article-title>Bezlotoxumab: a novel agent for the prevention of recurrent 
   <italic>Clostridium</italic> difficile infection
  </article-title>. 
  <source>Pharmacotherapy</source>. (
  <year>2017</year>) 
  <volume>37</volume>:
  <fpage>1298</fpage>â€“
  <lpage>308</lpage>. 
  <pub-id pub-id-type="doi">10.1002/phar.1990</pub-id>
  <?supplied-pmid 28730660?>
  <pub-id pub-id-type="pmid">28730660</pub-id>
 </mixed-citation>
</ref>
